DIVIS LABORATORIES
Back to Cashflow Statement
|
DIVIS LABORATORIES Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹-285 Cr | ₹50 Cr | ₹193 Cr | ₹-1,045 Cr | ₹-816 Cr |
What is the latest Net Cash Inflow / Outflow ratio of DIVIS LABORATORIES ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2026 | ₹-285 Cr |
| Mar2025 | ₹50 Cr |
| Mar2024 | ₹193 Cr |
| Mar2023 | ₹-1,045 Cr |
| Mar2022 | ₹-816 Cr |
How is Net Cash Inflow / Outflow of DIVIS LABORATORIES Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2026 | ₹-285 Cr | Negative | |
| Mar2025 | ₹50 Cr | -74.09 | |
| Mar2024 | ₹193 Cr | Positive | |
| Mar2023 | ₹-1,045 Cr | Negative | |
| Mar2022 | ₹-816 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹196,904.1 Cr | 1.2% | 10.5% | 7.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹473,509.0 Cr | 0.6% | 6% | 14.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,832.0 Cr | -0.4% | 11% | 40.8% | Stock Analytics | |
| CIPLA | ₹113,894.0 Cr | -1.6% | -2.1% | -4.8% | Stock Analytics | |
| MANKIND PHARMA | ₹105,357.0 Cr | -1% | 3.7% | -5.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,062.8 Cr | -4.6% | -14.8% | -8.4% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | 1.2% |
10.5% |
7.7% |
| SENSEX | -1.1% |
-0.2% |
-6.6% |
You may also like the below Video Courses